RT Journal Article
SR Electronic
T1 Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001701
DO 10.1136/jitc-2020-001701
VO 9
IS 2
A1 Ressler, Julia Maria
A1 Karasek, Matthias
A1 Koch, Lukas
A1 Silmbrod, Rita
A1 Mangana, Joanna
A1 Latifyan, Sofiya
A1 Aedo-Lopez, Veronica
A1 Kehrer, Helmut
A1 Weihsengruber, Felix
A1 Koelblinger, Peter
A1 Posch, Christian
A1 Kofler, Julian
A1 Michielin, Olivier
A1 Richtig, Erika
A1 Hafner, Christine
A1 Hoeller, Christoph
YR 2021
UL http://jitc.bmj.com/content/9/2/e001701.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.